Zentalis Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Zentalis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ZNTL.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded...
Can you invest in Zentalis Pharmaceuticals, Inc.?
Yes. Zentalis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ZNTL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zentalis Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.